Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST

Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
APTARGROUP, Inc. (NYSE: ATR) Delayed: 124.28 +3.67 (3.04%)
Previous Close $120.61    52 Week High $81.50 
Open $121.98    52 Week Low $66.33 
Day High $125.05    P/E 49.32 
Day Low $121.77    EPS $2.52 
Volume 404,909       

(NASDAQ: MIST) Delayed: 1.27 -0.03 (2.31%)
Previous Close $1.30    52 Week High
Open $1.30    52 Week Low
Day High $1.31    P/E N/A 
Day Low $1.26    EPS
Volume 730,647